NBY News and Press, NovaBay Pharmaceuticals Inc. From 09/21/23

JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces the commercial launch of Avenova Allograft to eyecare professionals across the U.S. through its physician-dispensed channel. This prescription product is the only optic allograft manufactured using BioStem Technologies, Inc.’...

2023-09-11 09:49:45 ET More on NovaBay Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Financial information for NovaBay NovaBay Pharmaceuticals, Inc. ( NBY ) Q2 2023 Earnings Call Transcript For further details...

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and BioStem Technologies, Inc. (OTC: BSEM) announce an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies’ Amniotic Tissue Allograft, which is intended for use as a protective covering during the...

MONTRÉAL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- NioBay Metals inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the start of a drilling campaign on the Crevier Property, which is owned by Les Minéraux Crevier Inc, of which NioBay...

2023-08-10 16:10:51 ET NovaBay press release ( NYSE: NBY ): Q2 GAAP EPS of -$1.27 misses by $0.71 . Revenue of $4.61M (+28.1% Y/Y) beats by $0.94M . For further details see: NovaBay GAAP EPS of -$1.27 misses by $0.71, revenue of $4.61M beats by $0.94M

Net product revenue of $4.6 million increased 26% over the prior-year quarter Wound care sales of $1.3 million mark a record quarterly high Sales and marketing expenses reduced by 16% through optimized digital marketing programs Operating loss decreased by 37% year-over-ye...

2023-08-09 17:35:09 ET NovaBay ( NYSE: NBY ) is scheduled to announce Q2 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$0.56 and the consensus Revenue Estimate is $3.67M (+20.7% Y/Y). Over the last 3 months, EPS estimates...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, July 20, 2023 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the closing of a pr...